Traditional Chinese medicinal composition for treating ovarian reserve decline disease and pharmaceutical application thereof

Abstract

The invention discloses a traditional Chinese medicinal composition for treating the ovarian reserve decline disease. The traditional Chinese medicinal composition is prepared from the following medicinal raw materials: rehmannia, rhizoma polygonati, parasitic loranthus, teasel root, glossy privet fruit, medlar, red-rooted salvia, radix curcumae and the like. The traditional Chinese medicinal composition has the efficacies of nourishing kidney, replenishing essence, nourishing blood, soothing the liver, nourishing Yin and raising Yang, mainly treats kidney essence insufficiency, liver depression and blood deficiency syndromes, and can be used for treating the ovarian reserve decline disease, preferably ovarian reserve hypofunction, premature ovarian insufficiency, premature ovarian failure, ovarian hyporesponsiveness, infertility and perimenopausal syndrome caused by the diseases and the like. Long-term clinical application proves that the traditional Chinese medicinal composition is exact in therapeutic effect, safe and free of side effects and has a broad clinical value.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine composition for treating diseases with decreased ovarian reserve function. In addition, the invention also relates to the pharmaceutical application of the traditional Chinese medicine composition. Background technique [0002] The ovary is an important female reproductive organ, with two major functions of reproduction and endocrine. The reproductive function includes the recruitment and development of follicles, the maturation and ovulation of follicles, and the formation and degeneration of the corpus luteum. Sex hormones (estrogen, progesterone, androgen), polypeptide hormones and growth factors, etc. Therefore, women's health is inseparable from the normal function of the ovaries. [0003] Ovarian reserve is the medical term for the primordial follicles contained within the cortex of a human female ovary. In women, ther...

AI Technical Summary

Problems solved by technology

The several drugs disclosed in the above two prior art are relatively lacking in the overall regulation of the body, because their treatment methods are different, so patients are required to clarify the luteal phase, menstrual period, follicular phase, and ovulation phase, etc., and for different periods. Disease syndrome and physical syndrome characteristics Take corresponding medicines, so the usage of medicines is complicated, and requires a high level of cognition of patients, it is extremely inconvenient to take, and it is easy for patients to have poor compliance and even the risk of misuse of medicines

[0018] The existing patent technology (publication number CN1134824A) discloses an oral liquid for regulating female sexual function. This invention focuses on the diagnosis and treatment of kidney-yang deficiency, and can be used to improve symptoms such as hyposexuality, vaginal dryness, and listlessness, while ignoring the balance of yin and yang. As well as the coordination of liver, spleen, kidney and other viscera

In addition, the existing patented technology (publication number CN107715074A) discloses a formula of traditional Chinese medicine wine for menopausal syndrome, which has the effect of invigorating qi and blood, and can improve the symptoms of menopausal discomfort, but this invention does not go from the fundamental pathogenesis of the disease Treatment does not achieve the effects of nourishing liver and kidney, regulating blood vessels, etc., and cannot improve and restore ovarian reserve function, and as medicinal wine, it is not suitable for pregnant women who need to take it

Images